Barometer Capital Management Inc. Kaleido Biosciences, Inc. Transaction History

Barometer Capital Management Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$5.02 - $8.87 $150,600 - $266,100	-30,000 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$11.25 - $18.1 $6,446 - $10,371	-573 Reduced 1.87%	30,000 $348,000
Q1 2019 Apr 18, 2019	BUY	$12.71 - $15.0 $388,582 - $458,595	30,573 New	30,573 $443,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Barometer Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Barometer Capital Management Inc. with notifications on news.